Literature DB >> 20623313

Catecholamines 101.

David S Goldstein1.   

Abstract

This review of clinical catecholamine neurochemistry is based on the Streeten Memorial Lecture at the 19th annual meeting of the American Autonomic Society and lectures at a satellite of the 6th Congress of the International Society of Autonomic Neuroscience. Here I provide historical perspective, describe sources and meanings of plasma levels of catecholamines and their metabolites, present a model of a sympathetic noradrenergic neuron that conveys how particular aspects of sympathetic nervous function affect plasma levels of catecholamines and their metabolites, and apply the model to understand plasma neurochemical patterns associated with some drugs and disease states.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20623313      PMCID: PMC3046107          DOI: 10.1007/s10286-010-0065-7

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  133 in total

1.  Plasma norepinephrine in congestive heart failure.

Authors:  J A Thomas; B H Marks
Journal:  Am J Cardiol       Date:  1978-02       Impact factor: 2.778

2.  Plasma dihydroxyphenylglycol and the intraneuronal disposition of norepinephrine in humans.

Authors:  D S Goldstein; G Eisenhofer; R Stull; C J Folio; H R Keiser; I J Kopin
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

3.  Effects of monoamine oxidase inhibitors on levels of catechols and homovanillic acid in striatum and plasma.

Authors:  D Hovevey-Sion; I J Kopin; R W Stull; D S Goldstein
Journal:  Neuropharmacology       Date:  1989-08       Impact factor: 5.250

4.  Effects of carbidopa and entacapone on the metabolic fate of the norepinephrine prodrug L-DOPS.

Authors:  David S Goldstein; Courtney Holmes; LaToya Sewell; Sandra Pechnik; Irwin J Kopin
Journal:  J Clin Pharmacol       Date:  2010-03-10       Impact factor: 3.126

5.  Patterns of plasma levels of catechols in neurogenic orthostatic hypotension.

Authors:  D S Goldstein; R J Polinsky; M Garty; D Robertson; R T Brown; I Biaggioni; R Stull; I J Kopin
Journal:  Ann Neurol       Date:  1989-10       Impact factor: 10.422

6.  The sympathetic-nervous-system defect in primary orthostatic hypotension.

Authors:  M G Ziegler; C R Lake; I J Kopin
Journal:  N Engl J Med       Date:  1977-02-10       Impact factor: 91.245

7.  Plasma dihydroxyphenylglycol for estimation of noradrenaline neuronal re-uptake in the sympathetic nervous system in vivo.

Authors:  G Eisenhofer; D S Goldstein; I J Kopin
Journal:  Clin Sci (Lond)       Date:  1989-02       Impact factor: 6.124

Review 8.  Takotsubo cardiomyopathy: a new form of acute, reversible heart failure.

Authors:  Yoshihiro J Akashi; David S Goldstein; Giuseppe Barbaro; Takashi Ueyama
Journal:  Circulation       Date:  2008-12-16       Impact factor: 29.690

9.  Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol.

Authors:  G Eisenhofer; D S Goldstein; T G Ropchak; H Q Nguyen; H R Keiser; I J Kopin
Journal:  J Auton Nerv Syst       Date:  1988-09

10.  Clinical laboratory evaluation of autoimmune autonomic ganglionopathy: Preliminary observations.

Authors:  David S Goldstein; Courtney Holmes; Richard Imrich
Journal:  Auton Neurosci       Date:  2009-01-19       Impact factor: 3.145

View more
  16 in total

1.  hTERT mediates norepinephrine-induced Slug expression and ovarian cancer aggressiveness.

Authors:  M J Choi; K H Cho; S Lee; Y J Bae; K J Jeong; S Y Rha; E J Choi; J H Park; J M Kim; J-S Lee; G B Mills; H Y Lee
Journal:  Oncogene       Date:  2014-08-25       Impact factor: 9.867

Review 2.  The clinical approach to autonomic failure in neurological disorders.

Authors:  Eduardo E Benarroch
Journal:  Nat Rev Neurol       Date:  2014-05-27       Impact factor: 42.937

3.  Acute Hypobaric Hypoxia Exposure Causes Neurobehavioral Impairments in Rats: Role of Brain Catecholamines and Tetrahydrobiopterin Alterations.

Authors:  Monojit Bhattacharjee; Suryaa Manoharan; Uma Maheswari Deshetty; Ekambaram Perumal
Journal:  Neurochem Res       Date:  2022-10-07       Impact factor: 4.414

4.  The trace amine theory of spontaneous hypertension as induced by classic monoamine oxidase inhibitors.

Authors:  Vincent Van den Eynde
Journal:  J Neural Transm (Vienna)       Date:  2021-08-09       Impact factor: 3.575

Review 5.  Catecholamine autotoxicity. Implications for pharmacology and therapeutics of Parkinson disease and related disorders.

Authors:  David S Goldstein; Irwin J Kopin; Yehonatan Sharabi
Journal:  Pharmacol Ther       Date:  2014-06-16       Impact factor: 12.310

6.  The Effects of Tryptophan Enhancement and Depletion on Plasma Catecholamine Levels in Healthy Individuals.

Authors:  Stephen H Boyle; Beverly H Brummett; Cynthia M Kuhn; John C Barefoot; Ilene C Siegler; Redford B Williams; Anastasia Georgiades
Journal:  Psychosom Med       Date:  2019-01       Impact factor: 4.312

7.  Congenital eyelid ptosis, decreased glomerular filtration, and orthostatic hypotension: Answers.

Authors:  Tessa Wassenberg; Michèl Willemsen; Henry Dijkman; Jaap Deinum; Leo Monnens
Journal:  Pediatr Nephrol       Date:  2016-11-17       Impact factor: 3.714

8.  Measurement of plasma norepinephrine and 3,4-dihydroxyphenylglycol: method development for a translational research study.

Authors:  Quin E Denfeld; Beth A Habecker; William R Woodward
Journal:  BMC Res Notes       Date:  2018-04-19

9.  Dopamine Modulates the Activity of Sensory Hair Cells.

Authors:  Cecilia Toro; Josef G Trapani; Itallia Pacentine; Reo Maeda; Lavinia Sheets; Weike Mo; Teresa Nicolson
Journal:  J Neurosci       Date:  2015-12-16       Impact factor: 6.167

10.  Evaluation and validation of a method for determining platelet catecholamine in patients with obstructive sleep apnea and arterial hypertension.

Authors:  Marcia C Feres; Fatima D Cintra; Camila F Rizzi; Luciane Mello-Fujita; Altay A Lino de Souza; Sergio Tufik; Dalva Poyares
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.